Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2012

View Archived Issues

Studies yield encouraging VRS-317 pharmacodynamic and safety data

Pfizer immunotherapeutic for inflammatory diseases shows promise in phase I trials

Epicutaneous patch for peanut allergy safe and effective in patients

Michael J. Fox Foundation extends support to biomarker research program

Insmed doses first patient in TARGET-NTM trial

Investigators in Israel design new mouse model of familial dysautonomia

Vorinostat in combination with bortezomib: Final results from VANTAGE trials

FDA approves Astellas drug for overactive bladder

Anthera updates phase III blisibimod plans

Gilead submits NDA for elvitegravir

Merrimack adds third arm to phase III trial in metastatic pancreatic cancer

FDA grants priority review to NDA for regorafenib

Novel PARP inhibitors developed in China

New formylpeptide receptor ligands patented by Allergan

Lilly presents novel MAP kinase p38 inhibitors

Research at Pfizer yields novel potential antibacterial drugs

New notum-directed antibodies may be useful to treat osteoporosis

Novel potential cancer immunotherapy designed in Korea

Synta reports on interim analysis of GALAXY trial

FDA accepts Shionogi NDA for review

Sanwa and Fuji submit application for hyperuricemia and gout treatment in Japan

Compugen shows potential of another B7/CD28-like protein target

SymBio opens enrollment in Japanese rigosertib trial

Astellas' Gonax approved in Japan

Vertex Pharmaceuticals announces final phase II data on VX-809/Kalydeco combination

Oxis Turbuhaler approved in Japan in different formulations

Eisai and Toyama Chemical obtain approval in Japan for rheumatoid arthritis drug

Japanese authorities approve Inlyta tablets

Mitsubishi Tanabe drug approved for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.